Status:
COMPLETED
Comparative Study in the Efficacy of Topical Besifloxocin With Erythromycin for the Management of Acute Blepharitis
Lead Sponsor:
John, George, M.D.
Collaborating Sponsors:
Bausch & Lomb Incorporated
Conditions:
Blepharitis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study looks at the improvements in signs and symptoms in patients with inflammation of the lids, blepharitis, using two different FDA approved topical antibiotic agents, Besifloxocin and Erythrom...
Detailed Description
This is a pilot project involving thirty patients with a specific form of inflammtion of the lids called anterior blepharitis. The patients are graded for their signs a symptoms and then randomized to...
Eligibility Criteria
Inclusion
- Acute blepharitis, age 18-100, Signs and symptoms of blepharitis -
Exclusion
- women of child bearing potential, eye surgery within three months of study, contact lens wear, use of topical or antibacterial agents in past two weeks, use of topical or oral steroids in past two weeks unless stable dosage
- \-
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01478256
Start Date
August 1 2011
End Date
October 1 2011
Last Update
December 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
George John, M.D.
Louisville, Kentucky, United States, 40205